Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2025 / November / Multimodal Imaging for MacTel / Summary
Retina Insights Opinions

Multimodal Imaging for MacTel

Employing multimodal imaging for the early detection of macular telangiectasia

By Eleonora M. Lad 11/19/2025 5 min read

Share

article Full Article subject Summary summarize Notecard
At Duke Eye Center, Dr. Lad presents a transformative understanding of macular telangiectasia (MacTel), once thought rare but now considered a common neurodegenerative condition affecting photoreceptors. The subtle early symptoms often resemble other macular diseases, complicating diagnosis. Early detection through multimodal imaging, particularly spectral-domain optical coherence tomography (SD-OCT), is crucial. While current imaging techniques help in diagnosis and monitoring, the development of AI-driven quantitative tools is essential for enhancing patient understanding of disease progression.

About the Author(s)

Eleonora M. Lad

Eleonora Lad, MD, PhD is Professor of Ophthalmology and Vice Chair for Ophthalmology Clinical Research at Duke University Medical Center in Durham, NC, where she practices in the Vitreoretinal Disease division.

More Articles by Eleonora M. Lad

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: